MoneyWorks4Me

Sun Pharmaceutical Industries submits press release

01 Aug 2019 Evaluate

Sun Pharmaceutical Industries has informed about submission of its Press Release relating to regulatory filing of Tildrakizumab in Japan, which the company shall be releasing after sending this letter. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1787.35
Dr. Reddys Labs. 1216.30
Cipla 1339.00
Lupin 2011.00
Zydus Lifesciences 1160.75
View more..